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Abstract 
Purpose: To synthesize and characterize S-alkylated/aralkylated 2-(1H-indol-3-ylmethyl)-1,3,4-
oxadiazole-5-thiol derivatives. 
Methods: 2-(1H-indol-3-yl)acetic acid (1) was reacted with absolute ethanol and catalytic amount of 
sulfuric acid to form ethyl 2-(1H-indol-3-yl)acetate (2) which was transformed to 2-(1H-indol-3-
yl)acetohydrazide (3) by refluxing with hydrazine hydrate in methanol. Ring closure reaction of 3 with 
carbon disulfide and ethanolic potassium hydroxide yielded 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-
thiol (4) which was finally treated with alkyl/aralkyl halides (5a-u) in DMF and NaH to yield S-
alkylated/aralkylated 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiols (6a-u). Structural elucidation was 
done by IR, 1H-NMR and EI-MS techniques 
Results: 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiol (4) was synthesized as the parent molecule 
and was characterized by IR and the spectrum showed peaks resonating at (cm-1) 2925 (Ar-H), 2250 
(S-H ), 1593 (C=N ) and 1527 (Ar C=C ); 1H-NMR spectrum showed signals at δ 11.00 (s, 1H, NH-1ʹ), 
7.49 ( br.d, J = 7.6 Hz, 1H, H-4'), 7.37 (br.d, J = 8.0 Hz, 1H, H-7'), 7.34 (br.s, 1H, H-2'), 7.09 (t, J = 7.6 
Hz, 1H, H-5'), 7.00 (t, J = 7.6 Hz, 1H, H-6') and 4.20 (s, 2H, CH2-10ʹ). EI-MS presented different 
fragments peaks at m/z 233 (C11H9N3OS)˙+ [M+2]+, 231 (C11H9N3OS)˙+ [M]+, 158 (C10H8NO)+, 156 
(C10H8N2)˙+, 130 (C9H8N)+. The derivatives (6a-6u) were prepared and characterized accordingly. 
Conclusion: S-alkylated/aralkylated 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiols (6a-u) were 
successfully synthesized.  
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INTRODUCTION 
 
The synthesis and analysis of chemical and 
biological behaviors of 2, 5-disubstituted-1,3,4-
oxadiazole-2-thiol derivatives have gained 
substantive importance in the past few decades 
for biological, medical and agricultural reasons 
[1-5]. Synthesis of 2,5-disubstituted 1,3,4-
oxadiazoles from acyl hydrazides and acids can 
be done by acid activation with CDI, followed by 
coupling with the required acyl hydrazide and 
dehydration in the same pot with CBr4 and Ph3P 
[6]. The appropriate aromatic acids are 
transformed to corresponding oxadiazoles 
through their hydrazides [7,8]. Substitution of 
alkyl/aralkyl halides can be done at 1, 3, 4-
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oxadiazole-2-thiol, to study structure-activity 
relationship [9]. 
 
Indole derivatives display a wide range of 
biological activities. 2-(1H-indol-3-yl) acetic acid 
is a plant growth hormone. It is obtained naturally 
from diets rich in vegetable stems and is 
synthesized from tryptophan, which is also used 
for the hormones serotonin and melatonin, the 
anti-inﬂammatory drug indomethacin, the 
psychotropic drug LSD and the anti-tumor agent 
vinblastine [10,11]. In continuation of our ongoing 
research efforts [12,13], we report herein the 
synthesis of alkylated/aralkylated 2-[1H-indol-3-
ylmethyl]-1,3,4-oxadiazole-5-thiols (6a-u) which 
might be employed for pharmacological 
evaluation in search of new drug candidates.  
 
EXPERIMENTAL  
 
Materials and instruments 
 
Alkyl halides were purchased from Sigma Aldrich 
and Alfa Aesar, while 3-indoleacetic acid and 
hydrated hydrazine were from DAE Jung. All 
solvents were obtained through local supplier 
and used after distillation. Thin layer 
chromatography (TLC) was carried out on pre-
coated silica gel G-25-UV254 plates, run in 
different ratios of EtOAc and n-hexane and 
visualized at UV 254 nm. Melting points of 
synthesized compounds were recorded on Griffin 
and George melting point apparatus by open 
capillary tube and were uncorrected; IR spectra, 
was recorded in KBr pellet method on a Jasco-
320-A spectrometer (Germany) in cm-1; 1H-NMR 
spectra were recorded in DMSO on a Bruker 
spectrometer (USA) at 300, 400 & 500 MHz with 
chemical shifts in ppm; and EIMS spectra were 
recorded on a JMS-HX-110 spectrometer with a 
data system.  
 
Synthesis 
 
Ethyl 2-(1H-indol-3-yl)acetate (2): 2-(1H-indol-
3-yl)acetic acid (20.0 g; 0.11 mol; 1) in absolute 
ethanol (60 mL) and catalytic amount of 
concentrated sulfuric acid (10 mL; 0.18 mol) 
were put into a round bottomed flask and 
refluxed for 8 h. The flask contents were then 
neutralized with 25 mL of 10 % Na2CO3 solution. 
The product was isolated by solvent extraction 
with chloroform. 
 
2-(1H-indol-3-yl)acetohydrazide (3): Ethyl 2-
(1H-indol-3-yl) acetate (19.0 mL; 2) and 80 % 
hydrazine hydrate (25 mL) in 30 mL methanol 
were put into a round bottomed flask. The 
reaction mixture was stirred for 3 h at room 
temperature and the resultant acid hydrazide 
was obtained by distilling methanol from the 
reaction mixture.  
 
2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-
thiol (4): 2-(1H-indol-3-yl) acetohydrazide (20.0 
g, 0.11 mol; 3) and absolute ethanol (30 mL) 
were put into a round bottom flask. Carbon 
disulfide (14.0 mL, 22 mol) was then added to 
the solution, followed by addition of potassium 
hydroxide (6.3 g, 0.11 mol). The mixture was 
refluxed for 6 h. and then diluted with distilled 
water (50 mL) and acidified with dilute 
hydrochloric acid to pH 2-3. The precipitate thus 
formed was filtered, washed with water and re-
crystallized in ethanol. 
 
S-alkylated/aralkylated 2-(1H-indol-3-
ylmethyl)-1, 3, 4-oxadiazole-5-thiols (6a-u): 2-
(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiol 
(0.20 g; 0.001 mol; 4) as a nucleophile in N,N-
dimethyl formamide was placed in a round 
bottom flask followed by addition of sodium 
hydride (0.002 g, 0.1 mmol) to the reaction 
mixture, which was then stirred for about half an 
hour at room temperature. The electrophiles, 
alkyl/aralkyl halides (5a-5u), were added in 
stoichiometric amounts and stirred for 8 h. After 
completion of reaction, the derivatives (6a-6u) 
were obtained as precipitates by addition of 
distilled water or by solvent extraction depending 
on the nature of the product. 
 
RESULTS 
 
The S-substituted derivatives (6a-6u) of  2-(1H-
indol-3-yl-methyl)-1,3,4-oxadiazole-5-thiol (4) 
were synthesized by the protocol sketched in 
Scheme 1 and the different S-substituted 
alkyl/aralkyl groups are listed in Table 1 while the 
spectral and mass fragmentation patterns  are 
shown in Fig 1-4. The spectral characterizations 
of the compounds are provided below. 
 
2-(1H-indol-3-yl)acetate (2): Brownish liquid, 
Yield: 85 %; Molecular formula: C12H13NO2; 
Molecular weight: 203 gmol-1; IR (KBr) vmax: 3315 
(N-H), 2930 (Ar-H), 1624 (C=O ), 1531 (Ar. C=C 
); 1H-NMR (400 MHz, DMSO-d6): δ 10.9 (s, 1H, 
NH-1ʹ), 7.48 ( br.d, J = 8.0 Hz, 1H, H-4'), 7.34 
(br.d, J = 8.0 Hz, 1H, H-7'), 7.23 (br.s, 1H, H-2'), 
7.06 (t, J = 7.6 Hz, 1H, H-5'), 6.97 (t, J = 7.6 Hz, 
1H, H-6'),4.16 (q, J= 7.2, 2H, -OCH2CH3), 3.71 
(s, 2H, CH2-10ʹ),1.17 (t, J = 7.2 Hz, 3H, -
OCH2CH3). EIMS: m/z 203 (C12H13NO2)˙+ [M]+, 
158 (C10H8NO)+, 130 (C9H8N)+, 73 (C3H5O2)+. 
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Scheme 1: Steps in the synthesis of S-alkylated/aralkylated 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiols 
(6a-6u) 
 
Table 1: S-Alkylated/aralkylated 2-(1H-indol-3-ylmethyl)-1,3,4-oxadiazole-5-thiols (6a-u) 
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Figure 1: 1H-NMR spectrum of 3-{[5-(Allylsulfanyl)-1,3,4-oxadiazol-2-yl]methyl}-1H-indole (6i) 
 
 
 
Figure 2: 1H-NMR spectrum of 3-[(5-(Ethoxycarbonylmethylsulfanyl)-1,3,4-oxadiazole-2-yl)methyl]-1H-indole (6j) 
 
2-(1H-indol-3-yl)acetohydrazide (3): Brownish 
crystals; Yield: 89 %; M.P. 113 °C; Molecular 
formula: C10H11N3O; Molecular weight: 189 gmol-
1; IR (KBr) vmax: 3310 (N-H), 2930 (Ar-H), 1630 
(C=O ), 1529 (Ar. C=C ); 1H-NMR (400 MHz, 
DMSO-d6): δ 10.8 (s, 1H, NH-1ʹ),9.08 (s, 1H, 
NHNH2), 7.55 ( br.d, J = 7.6 Hz, 1H, H-4'), 7.31 
(br.d, J = 8.0 Hz, 1H, H-7'), 7.16 (br.s, 1H, H-2'), 
7.04 (t, J = 7.2 Hz, 1H, H-5'), 6.95 (t, J = 7.6 Hz, 
1H, H-6'), 4.16 ( s,1H, NHNH2) 3.43 (s, 2H, CH2-
10ʹ). EIMS: m/z 203 (C10H11N3O)˙+ [M]+, 158 
(C10H8NO)+, 130 (C9H8N)+, 59 (C3H5O2)+. 
 
2-(1H-indol-3-yl-methyl)-1,3,4-oxadiazole-5-
thiol (4): Dark brown powder; Yield: 76 %; M.P. 
125 °C; Molecular formula: C11H9N3OS; 
Molecular weight: 231 gmol-1; IR (KBr) vmax: 2925 
(Ar-H), 2250 (S-H ), 1593 (C=N ), 1527 (Ar C=C ) 
; 1H-NMR (400 MHz, DMSO-d6 ): δ 11.0 (s, 1H, 
NH-1ʹ), 7.49 ( br.d, J = 7.6 Hz, 1H, H-4'), 7.37 
(br.d, J = 8.0 Hz, 1H, H-7'), 7.34 (br.s, 1H, H-2'), 
7.09 (t, J = 7.6 Hz, 1H, H-5'), 7.00 (t, J = 7.6 Hz, 
1H, H-6'), 4.20 (s, 2H, CH2-10ʹ). EIMS: m/z 233 
(C11H9N3OS)˙+ [M+2]+, 231 (C11H9N3OS)˙+ [M]+, 
158 (C10H8NO)+, 156 (C10H8N2)˙+, 130 (C9H8N)+. 
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Figure 3: 1H-NMR spectrum of 3-({5-[(3-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1H-indole (6u) 
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Fig 4: Mass fragmentation pattern 3-({5-[(3-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-1H-indole (6u) 
 
3-({5-[(2-Bromoethyl)sulfanyl]-1,3,4-oxadiazol-
2-yl}methyl)-1H-indole (6a): Light brown 
amorphous solid; Yield: 81 %; M.P. 146 °C; 
Molecular formula: C13H12N3OSBr; Molecular 
weight: 338 gmol-1; IR (KBr): vmax  3226 (N-H), 
2910 (C-H Ar), 1484 (C=N), 1476 (C=C Ar), 840 
(C-N) and 810 (C-S);  1H-NMR (300 MHz, 
DMSO-d6): δ 11.0 (s, 1H, NH-1ʹ), 7.47 (br.d, J = 
7.8 Hz, 1H, H-4'), 7.35 (br.d, J = 7.8 Hz, 1H, H-
7'), 7.31 (br.s, 1H, H-2'), 7.09 (t, J = 6.9 Hz, 1H, 
H-5'), 6.98 (t, J = 7.2 Hz, 1H, H-6'), 4.13 (s, 2H, 
CH2-10ʹ), 3.22-3.25 (m-overlapped, 4H, CH2-1'' & 
CH2-2''); EIMS: m/z 341 (C13H12N3OSBr)˙+ 
[M+4]+,  339 (C13H12N3OSBr)˙+ [M+2]+, 337 
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(C13H12N3OSBr)˙+ [M]+, 233 (C11H9N3OS)+,  231 
(C11H9N3OS)+, 198 (C11H8N3O)+,  172 
(C10H8NO)+, 170 (C10H8N3)+, 158 (C10H8NO)+,  
158 (C6H4Br+2)+, 156 (C6H4Br)+, 156 (C10H8N2)˙+, 
130 (C9H8N)+, 110 (C2H4Br)+,108 (C2H4Br)+. 
 
3-({5-[(2-Chloroethyl)sulfanyl]-1,3,4-oxadiazol-
2-yl}methyl)-1H-indole (6b): Light brown 
amorphous solid; Yield: 85 %; M.P. 208 °C; 
Molecular formula: C13H12N3OSCl;  Molecular 
weight: 293.5 gmol-1; IR (KBr): vmax: 3221 (N-H), 
2919 (C-H Ar),  1484 (C=N), 1470 (C=C Ar), 843 
(C-N) and 814 (C-S); 1H-NMR (500 MHz, DMSO-
d6 ): δ 10.99 (s, 1H, NH-1ʹ), 7.51 (br.d, J = 8.0 
Hz, 1H, H-4'), 7.38 (br.d, J = 8.0 Hz, 1H, H-7'), 
7.33 (br.s, 1H, H-2'), 7.10 (t, J = 8.0 Hz, 1H, H-
5'), 7.00 (t, J = 8.0 Hz, 1H, H-6'), 4.34 (s, 2H, 
CH2-10ʹ), 3.91 (t, 2H, J = 7.0 Hz, CH2-2''), 3.56 (t, 
2H, J = 7.0 Hz, CH2-1''); EIMS: m/z 297 
(C13H12N3OSCl)˙+ [M+4]+,  295 (C13H12N3OSCl)˙+ 
[M+2]+, 293 (C13H12N3OSCl)˙+ [M]+, 233 
(C11H9N3OS+2)+,  231 (C11H9N3OS)+, 198 
(C11H8N3O)+,  172 (C10H8N2O)+, 170 (C10H8N3)+, 
158 (C10H8NO)+,  156 (C10H8N2)˙+, 130(C9H8N)+, 
65 (C2H4Cl+2)+, 63 (C2H4Cl)+. 
 
3-{[5-(Propylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6c): Brown amorphous 
solid; Yield: 70 %; M.P. 103°C; Molecular 
formula:  C14H15N3OS; Molecular weight: 273 
gmol-1; IR (KBr): vmax: 3225 (N-H), 2932 (C-H Ar), 
1479 (C=N), 1474 (C=C Ar), 840 (C-N) and 816 
(C-S); 1H-NMR (400 MHz, DMSO-d6): δ 11.0 (s, 
1H, NH-1ʹ), 7.47 (br.d, J = 7.6 Hz, 1H, H-4'), 7.35 
(br.d, J = 7.6 Hz, 1H, H-7'), 7.31 (br.s, 1H, H-2'), 
7.09 (t, J = 6.8 Hz, 1H, H-5'), 6.98 (t, J = 7.2 Hz, 
1H, H-6'), 4.16 (s, 2H, CH2-10'), 3.84 (t, J = 7.6 
Hz, 2H, CH2-1''), 1.64 (sex, J = 7.2 Hz, 2H, CH2-
2''), 1.05 (t, J = 7.2 Hz, 3H, CH3-3''); EIMS: m/z 
275 (C14H15N3OS)˙+ [M+2]+, 273 (C14H15N3OS)˙+ 
[M]+, 233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 
198 (C11H8N3O)+, 172 (C10H8N2O)+, 170 
(C10H8N3)+, 158 (C10H8NO)+,  156 (C10H8N2)˙+, 
130 (C9H8N)+,43(C3H7)+. 
 
3-{[5-(iso-Propylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6d): Light brown 
amorphous solid; Yield: 75 %; M.P. 78 °C; 
Molecular formula: C14H15N3OS; Molecular 
weight: 273 gmol-1; IR (KBr): vmax: 3225 (N-H), 
2928 (C-H Ar), 1478 (C=N), 1470 (C=C Ar), 845 
(C-N) and 809 (C-S); 1H-NMR (500 MHz, DMSO-
d6 ): δ 11.02 (s, 1H, NH-1ʹ), 7.50 (br. d, J = 8.0 
Hz, 1H, H-4'), 7.37 (br. d, J = 8.0 Hz, 1H, H-7'), 
7.33 (br. s, 1H, H-2'), 7.10 (t, J = 7.0 Hz, 1H, H-
5'), 7.00 (t, J = 7.5 Hz, 1H, H-6'), 4.78 (s, 2H, 
CH2-10ʹ), 3.76-3.71 (m, 1H, CH-1''), 1.36 (d, J = 
6.0 Hz, 6H, CH3-2'' & CH3-3''); EIMS: m/z 275 
(C14H15N3OS)˙+ [M+2]+,  273 (C20H19N3OS)˙+ 
[M]+, 233 (C11H9N3OS+2)+,  231( C14H15N3OS)+, 
198 (C11H8N3O)+, 172 (C10H8N2O)+, 170 
(C10H8N3)+, 158 (C10H8NO)+,  156 (C10H8N2)˙+, 
130 (C9H8N)+, 43 (C3H7)+. 
 
3-{[5-(sec-Butylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6e): Dark brown sticky 
solid; Yield: 73 %; Molecular formula: 
C15H17N3OS; Molecular weight: 287 gmol-1; IR 
(KBr): vmax: 3220 (N-H), 2930 (C-H Ar), 1485 
(C=N), 1472 (C=C Ar), 838 (C-N) and 814 (C-S); 
1H-NMR (400 MHz, DMSO-d6): δ 11.0 (s, 1H, 
NH-1ʹ), 7.47 (br. d, J = 7.6 Hz, 1H, H-4'), 7.35 
(br. d, J = 8.0 Hz, 1H, H-7'), 7.31 (br. s, 1H, H-2'), 
7.09 (t, J = 6.8 Hz, 1H, H-5'), 6.98 (t, J = 7.2 Hz, 
1H, H-6'), 4.43 (s, 2H, CH2-10ʹ), 4.25-4.21 (m, 
1H, H-1"), 1.01 (d, J = 6.8 Hz, 3H, CH3-4"), 0.90-
0.85 (m, 2H, H-2"), 0.74 (t, J = 7.2 Hz, 3H, CH3-
3"). EIMS: m/z 289 (C15H17N3OS)˙+ [M+2]+, 287 
(C15H17N3OS)˙+ [M]+, 233 (C11H9N3OS+2)+,  231 
(C11H9N3OS)+, 198 (C11H8N3O)+, 172 
(C10H8N2O)+, 170 (C10H8N3)+, 158 (C10H8NO)+,  
156 (C10H8N2)˙+, 130 (C9H8N)+, 58 (C4H9)+, 43 
(C3H6)˙+. 
 
3-{[5-(Butylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6f): Brown amorphous 
solid; Yield: 87 %; M.P. 83 °C; Molecular 
formula: C15H17N3OS; Molecular weight: 287 
gmol-1; IR (KBr): vmax: 3220 (N-H), 2925 (C-H Ar), 
1480 (C=N), 1477 (C=C Ar), 839 (C-N) and 805 
(C-S); 1H-NMR (500 MHz, DMSO-d6): δ 11.02 (s, 
1H, NH-1ʹ), 7.49 (br. d, J = 8.0 Hz, 1H, H-4'), 
7.37 (br.d, J = 8.5 Hz, 1H, H-7'), 7.32 (br.s, 1H, 
H-2'), 7.09 (t, J = 8.0 Hz, 1H, H-5'), 6.99 (t, J = 
7.5 Hz, 1H, H-6'), 4.25 (s, 2H, CH2-10ʹ), 3.15 (t, J 
= 7.5 Hz, 2H, CH2-1''), 1.61 (quint., J = 7.5 Hz, 
2H, CH2-2''), 1.31 (sext, J = 7.0 Hz, 2H, CH2-3''), 
0.84 (t, J = 7.5 Hz, 3H, CH3-4''). EIMS: m/z 289 
(C15H17N3OS)˙+ [M]+,  287 (C15H17N3OS)˙+ [M]+, 
233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 172 
(C10H8N2O)+, 170 (C10H8N3)+, 158 (C10H8NO)+,  
156 (C10H8N2)˙+, 130 (C9H8N)+, 58 (C4H9)+, 42 
(C3H6)˙+. 
 
3-{[5-(Pentylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6g): Brown amorphous 
solid; Yield: 78 %; M.P. 62 °C; Molecular 
formula: C16H19N3OS; Molecular weight: 301 
gmol-1; IR (KBr): vmax: 3224 (N-H), 2927 (C-H Ar), 
1484 (C=N), 1470 (C=C Ar), 847 (C-N) and 812 
(C-S); 1H-NMR (500 MHz, DMSO-d6): δ 11.03 (s, 
1H, NH-1ʹ), 7.46 (br. d, J = 8.0 Hz, 1H, H-4'), 
7.33 (br. d, J = 8.0 Hz, 1H, H-7'), 7.29 (br. s, 1H, 
H-2'), 7.06 (t, J = 7.0 Hz, 1H, H-5'), 6.96 (t, J = 
7.5 Hz, 1H, H-6'), 4.29 (s, 2H, CH2-10ʹ), 3.11 (t, J 
= 7.5 Hz, 2H, CH2-1''), 1.61 (quint., 2H, CH2-2''), 
1.38-1.17 (m, 4H, CH2-3'', CH2-4''), 0.79 (t, J = 
7.0 Hz, 3H, CH3-5''); EIMS: m/z m/z 303 
(C16H19N3OS)˙+ [M+2]+, 301 (C16H19N3OS)˙+ [M]+, 
233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 198 
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(C11H8N3O)+, 172 (C10H8NO)+, 170 (C10H8N3)+, 
158 (C10H8NO)+,  156 (C10H8N2)˙+, 130 (C9H8N)+, 
71 (C5H11)+, 55(C4H7)˙+. 
 
3-{[5-(Heptylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6h): Dark brown 
amorphous solid; Yield: 88 %; M.P. 133 °C; 
Molecular formula: C18H23N3OS; Molecular 
weight: 329 gmol-1; IR (KBr): vmax: 3225 (N-H), 
2931 (C-H Ar), 1480 (C=N), 1475 (C=C Ar), 845 
(C-N) and 810 (C-S); 1H-NMR (400 MHz, DMSO-
d6): δ 11.0 (s, 1H, NH-1ʹ), 7.47 (br.d, J = 7.6 Hz, 
1H, H-4'), 7.35 (br.d, J = 7.6 Hz, 1H, H-7'), 7.31 
(br.s, 1H, H-2'), 7.09 (t, J = 6.8 Hz, 1H, H-5'), 
6.98 (t, J = 7.2 Hz, 1H, H-6'), 4.17 (s, 2H, CH2-
10ʹ),3.67-3.64 (m, 1H, H-1"), 2.02-1.97 (m, 4H, 
H-2" & H-3"), 1.25-1.18 (m, 6H, H-4" to H-6"), 
0.82 (t, J = 7.2 Hz, 3H, CH3-7"); EIMS: m/z 331 
(C18H23N3OS)˙+ [M+2]+, 329 (C18H23N3OS)˙+ [M]+, 
233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 198 
(C11H8N3O)+, 172 (C10H8N2O)+, 170 (C10H8N3)+, 
158 (C10H8NO)+,  156 (C10H8N2)˙+, 130 (C9H8N)+, 
99 (C7H14)+, 84 (C6H12)˙+, 56 (C4H8)˙+. 
 
3-{[5-(Allylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6i): Dark brown shiny 
solid; Yield: 76 %; M.P. 105 °C; Molecular 
formula: C14H14N3OS; Molecular weight: 272 
gmol-1; IR (KBr): vmax: 3226 (N-H), 2933 (C-H Ar),  
1481 (C=N), 1470 (C=C Ar), 843 (C-N) and 812 
(C-S); 1H-NMR (500 MHz, DMSO-d6): δ 11.01 (s, 
1H, NH-1ʹ), 7.48 (br.d, J = 8.0 Hz, 1H, H-4'), 7.36 
(br.d, J = 8.5 Hz, 1H, H-7'), 7.31 (br. s, 1H, H-2'), 
7.08 (t, J = 7.5 Hz, 1H, H-5'), 6.98 (t, J = 8.0 Hz, 
1H, H-6'), 5.90-5.80 (m, 1H, H-2''), 5.14 (dd, J = 
17.0, 1.5 Hz, 1H, Hb-3"), 5.08 (dd, J = 10.0, 0.5 
Hz, 1H, Ha-3"), 4.31 (s,2H, CH2-10ʹ), 3.80 (d, J = 
6.9 Hz, 2H, CH2-1''). EIMS: m/z 274 
(C14H14N3OS)˙+ [M+2]+, 272 (C14H14N3OS)˙+ [M]+, 
233 (C11H9N3OS+2)+,  231 (C11H9N3OS)+, 198 
(C11H8N3O)+, 172 (C10H8N2O)+, 170 (C10H8N3)+, 
158 (C10H8NO)+,  156 (C10H8N2)˙+, 130 (C9H8N)+, 
41 (C3H5)+. 
 
3-[(5-(Ethoxycarbonylmethylsulfanyl)-1,3,4-
oxadiazole-2-yl)methyl]-1H-indole (6j): Dark 
brown shiny solid; Yield: 82 %; M.P. 97 °C; 
Molecular formula: C15H15N3O3S; Molecular 
weight: 317 gmol-1; IR (KBr): vmax: 3225 (N-H), 
2934 (C-H Ar), 1484 (C=N), 1470 (C=C Ar), 840 
(C-N) and 814 (C-S); 1H-NMR (500 MHz, DMSO-
d6): δ 11.04 (s, 1H, NH-1ʹ ), 7.48 (br.d, J = 8.0 
Hz, 1H, H-4'), 7.36 (br.d, J = 8.0 Hz, 1H, H-7' ), 
7.30 (br.s, 1H, H-2' ), 7.08 (t, J = 7.0 Hz, 1H, H-
5'), 6.98 (t, J = 8.0 Hz, 1H, H-6'), 4.31 (s, 2H, 
CH2-10ʹ), 4.12 (s, 2H, CH2-1''' ), 4.04 (q, J = 7.2 
Hz, 2H, CH2-1'' ), 1.11 (t, J = 7.0 Hz, 3H, CH3-2'' 
); EIMS: m/z 319 (C15H15N3O3S)˙+ [M+2]+,317 
(C15H15N3O3S)˙+ [M]+, 233 (C11H9N3OS+2)+, 231 
(C11H9N3OS)+, 198 (C11H8N3O)+, 172 
(C10H8N2O)+, 170 (C10H8N3)+, 158 (C10H8NO)+, 
156 (C10H8N2)˙+, 130 (C9H8N)+, 87 [C4H7O2]+, 42 
[C2H2O]+.    
 
3-{[5-(Benzylsulfanyl)-1,3,4-oxadiazol-2-
yl]methyl}-1H-indole (6k): Light brown 
amorphous solid; Yield: 79 %; M.P. 110 °C; 
Molecular formula: C18H15N3OS; Molecular 
weight: 321 gmol-1; IR (KBr): vmax: 3224 (N-H), 
2928 (C-H Ar), 1486 (C=N), 1477 (C=C Ar), 838 
(C-N) and 810 (C-S); 1H-NMR (400 MHz, DMSO-
d6): δ 11.02 (s, 1H, NH-1ʹ), 7.49 (br.d, J = 8.0 Hz, 
1H, H-4'), 7.38 (br.d, J = 8.5 Hz, 1H, H-7'), 7.32 
(br.s, 1H, H-2'), 7.28- 7.25 (m, 2H, H-2''& H-6''), 
7.24- 7.19 (m, 3H, H-3'' to H-5''), 7.11 (t, J = 8.0 
Hz, 1H, H-5'), 7.00 (t, J = 8.0 Hz, 1H, H-6'), 4.35 
(s, 2H, CH2-10'), 4.25 (s, 2H, CH2-7'' ); EIMS: 
m/z  323 (C18H15N3OS)˙+ [M+2]+, 321 
(C18H15N3OS)˙+ [M]+, 233 (C11H9N3OS+2)+,  231 
(C11H9N3OS)+, 198 (C11H8N3O)+, 172 
(C10H8N2O)+, 170 (C10H8N3)+, 158 (C10H8NO)+, 
156 (C10H8N2)˙+, 130 (C9H8N)+,91 (C7H7)+, 65 
(C5H5)+.  
 
3-({5-[(3-Phenylethyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6l): Dark 
brown solid; Yield: 80 %; M.P. 75 °C; Molecular 
formula: C19H17N3OS; Molecular weight: 335 
gmol-1; IR (KBr): vmax: 3215 (N-H), 2930 (C-H Ar), 
1485 (C=N), 1479 (C=C Ar), 846(C-N) and 810 
(C-S); 1H-NMR (400 MHz, DMSO-d6): δ 11.0 (s, 
1H, NH-1ʹ), 7.49 (br.d, J = 7.6 Hz, 1H, H-4'), 7.36 
(br.d, J = 8.0 Hz, 1H, H-7'),7.33 (br.s, 1H, H-2'), 
7.26-7.22 (m, 3H, H-3'', H-4'' & H-5''), 7.18-7.12 
(m,2H, H-2'' & H-6''), 7.09 (t, J = 7.6 Hz, 1H, H-
5'), 6.98 (t, J = 7.6 Hz, 1H, H-6'), 4.32 (s, 2H, 
CH2-10'), 3.39 (t, J = 7.2 Hz, 2H, CH2-8''), 2.95 (t, 
J = 7.6 Hz, 2H, CH2-7''); EIMS: m/z 337 
(C19H17N3OS)˙+ [M+2]+,  335 (C19H17N3OS)˙+ 
[M]+, 233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 
198 (C11H8N3O)+, 172 (C10H8N2O)+, 170 
(C10H8N3)+, 158 (C10H8NO)+, 156 (C10H8N2)˙+, 
130 (C9H8N)+,105 (C8H9)+, 91 (C7H7)+, 65 
(C5H5)+. 
 
3-({5-[(3-Phenylpropyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6m): Dark 
brown shiny powder; Yield: 77 %; M.P. 64 °C; 
Molecular formula: C20H19N3OS; Molecular 
weight: 349 gmol-1; IR (KBr): vmax: 3225 (N-H), 
2927 (C-H Ar), 1484 (C=N), 1476 (C=C Ar), 847 
(C-N) and 812 (C-S); 1H-NMR (300 MHz, DMSO-
d6): δ 11.0 (s, 1H, NH-1ʹ), 7.47 (br.d, J = 7.8 Hz, 
1H, H-4'), 7.35 (br.d, J = 7.8 Hz, 1H, H-7'), 7.31 
(br.s, 1H, H-2'), 7.27-7.23 (m, 3H, H-3'', H-4'' & 
H-5''), 7.18-7.12 (m,2H, H-2'' & H-6''),7.08 (t, J = 
7.2 Hz, 1H, H-5'), 6.97 (t, J = 6.9 Hz, 1H, H-6'), 
4.31 (s, 2H, CH2-10'), 3.15 (t, J = 7.2 Hz, 2H, 
CH2-9''), 2.63 (t, J = 8.1 Hz, 2H, CH2-7''), 1.94 
(quint., J = 7.5 Hz, 2H, CH2-8''); EIMS: m/z 351 
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(C20H19N3OS)˙+ [M+2]+, 349 (C20H19N3OS)˙+ [M]+, 
233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 198 
(C11H8N3O)+, 172 (C10H8N2O)+, 170 (C10H8N3)+, 
158 (C10H8NO)+, 156 (C10H8N2)˙+, 130 
(C9H8N)+,119 (C9H11)+, 91 (C7H7)+, 65 (C5H5)+. 
 
3-({5-[(2-Chlorobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6n): Dark 
brown amorphous solid; Yield: 83 %; M.P. 126 
°C; Molecular formula: C18H14N3OSCl; Molecular 
weight: 355.5 gmol-1; IR (KBr): vmax: 3230 (N-H), 
2929 (C-H Ar), 1480 (C=N), 1472 (C=C Ar), 
8441(C-N) and 812 (C-S); 1H-NMR (400 MHz, 
DMSO-d6): δ 11.0 (s, 1H, NH-1ʹ), 7.47 (br.d, J = 
8.0 Hz, 1H, H-4'), 7.35 (br.d, J = 7.6 Hz, 1H, H-
7'), 7.34 (br.s, 1H, H-2'),7.32 (dd, J = 1.2, 8.0 Hz, 
1H, H-3''), 7.29 (br.d, J = 7.6 Hz, 1H, H-6''), 7.16-
7.10 (m, 2H, H-4'' & H-5''), 7.08 (t, J = 7.2 Hz, 
1H, H-5'), 6.97 (t, J = 6.8 Hz, 1H, H-6'), 4.55 (s, 
2H, CH2-7''), 4.31 (s, 2H, CH2-10'); EIMS: m/z 
359 (C18H14N3OSCl)˙+ [M+4]+, 357 
(C18H14N3OSCl)˙+ [M+2]+, 355 (C18H14N3OSCl)˙+ 
[M]+, 233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 
198 (C11H8N3O)+, 172 (C10H8N2O)+, 170 
(C10H8N3)+, 158 (C10H8NO)+, 156 (C10H8N2)˙+, 
130 (C9H8N)+, 127 (C7H6Cl+2)+, 125 (C7H6Cl)+, 
101 (C5H4Cl+2)+, 99 (C5H4Cl)+, 90 (C7H6)+, 64 
(C5H4)+.     
 
3-({5-[(3-Chlorobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6o): Dark 
brown amorphous solid; Yield: 89 %; M.P. 85 °C; 
Molecular formula: C18H14N3OSCl; Molecular 
weight: 355.5 gmol-1; IR (KBr): vmax: 3219 (N-H), 
2926 (C-H Ar), 1477 (C=N), 1478 (C=C Ar), 
840(C-N) and 812 (C-S); 1H-NMR (300 MHz, 
DMSO-d6): δ 11.01 (s, 1H, NH-1ʹ), 7.39 (br.s, 1H, 
H-2''), 7.36 (br.d, J = 8.6 Hz, 1H, H-4''), 7.35 
(br.d, J = 7.5 Hz, 1H, H-6''), 7.33 (br.t, J = 8.1 Hz, 
1H, H-5''), 7.31 (br.d, J = 7.8 Hz, 1H, H-4'), 7.30 
(br.d, J = 8.1Hz, 1H, H-7'), 7.29 (br.s, 1H, H-2'), 
7.11 (t, J = 7.2 Hz, 1H, H-5'), 6.97 (t, J = 7.2 Hz, 
1H, H-6'), 4.54 (s, 2H, CH2-7''), 4.30 (s, 2H, CH2-
10'); EIMS: m/z 359 (C18H14N3OSCl)˙+ [M+4]+, 
357 (C18H14N3OSCl)˙+ [M+2]+, 355 
(C18H14N3OSCl)˙+ [M]+, 233 (C11H9N3OS+2)+, 231 
(C11H9N3OS)+, 198 (C11H8N3O)+, 172 
(C10H8N2O)+, 170 (C10H8N3)+, 158 (C10H8NO)+, 
156 (C10H8N2)˙+, 130 (C9H8N)+, 127 (C7H6Cl+2)+, 
125 (C7H6Cl)+, 101 (C5H4Cl+2)+, 99 (C5H4Cl)+, 90 
(C7H6)+, 64 (C5H4)+.   
 
3-({5-[(4-Chlorobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6p): Brown 
colored amorphous solid; Yield: 79 %; M.P. 121 
°C; Molecular formula: C18H14N3OSCl; Molecular 
weight: 355.5 gmol-1; IR (KBr): vmax: 3215 (N-H), 
2928 (C-H Ar),  1480 (C=N), 1470 (C=C Ar), 
840(C-N) and 812 (C-S); 1H-NMR (300 MHz, 
DMSO-d6):  δ11.01 (s, 1H, NH-1ʹ), 7.49 (br.d, J = 
7.8 Hz, 1H, H-4'), 7.42 (br.d, J = 7.2 Hz, 1H, H-
7'), 7.37 (br.d, J = 8.4 Hz, 2H, H-2ʹʹ& H-6ʹʹ), 7.35 
(br.s, 1H, H-2'), 7.30 (br.d, J = 8.4 Hz, 2H, H-3'' & 
H-5''), 7.09 (t, J = 6.9 Hz, 1H, H-5'), 6.98 (t, J = 
7.2 Hz, 1H, H-6'), 4.55 (s, 2H, CH2-7''), 4.31 (s, 
2H, CH2-10'); EIMS: m/z 359 (C18H14N3OSCl)˙+ 
[M+4]+, 357 (C18H14N3OSCl)˙+ [M+2]+, 355 
(C18H14N3OSCl)˙+ [M]+, 233 (C11H9N3OS+2)+, 231 
(C11H9N3OS)+, 198 (C11H8N3O)+,   172 
(C10H8N2O)+,  170 (C10H8N3)+, 158 (C10H8NO)+, 
156 (C10H8N2)˙+, 130 (C9H8N)+, 127 (C7H6Cl+2)+, 
125 (C7H6Cl)+, 101 (C5H4Cl+2)+, 99 (C5H4Cl)+, 90 
(C7H6)+, 64 (C5H4)+.     
 
3-({5-[(2-Bromobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6q): Light 
brown amorphous solid; Yield: 85 %; M.P. 133 
°C; Molecular formula: C18H14N3OSBr; Molecular 
weight: 399 gmol-1; IR (KBr): vmax: 3217 (N-H), 
2935 (C-H Ar), 1479 (C=N), 1481 (C=C Ar), 846 
(C-N) and 816 (C-S); 1H-NMR (400 MHz, DMSO-
d6): δ 11.02 (s, 1H, NH-1ʹ), 7.47 (br.d, J = 7.6 Hz, 
1H, H-4'), 7.35 (br.d, J = 7.6 Hz, 1H, H-7'), 7.31 
(br.s, 1H, H-2'), 7.29 (dd, J = 1.2, 8.0 Hz, 1H, H-
3''), 7.28 (br.d, J = 7.6 Hz, 1H, H-6''), 7.11-7.09 
(m, 2H, H-4'' & H-5''), 7.07 (t, J = 7.2 Hz, 1H, H-
5'), 6.96 (t, J = 7.6 Hz, 1H, H-6'), 4.55 (s, 2H, 
CH2-7''), 4.29 (s, 2H, CH2-10'); EIMS: m/z 403 
(C18H14N3OSBr)˙+ [M+4]+,  401 (C18H14N3OSBr)˙+ 
[M+2]+, 399 (C18H14N3OSBr)˙+ [M]+, 233 
(C11H9N3OS+2)+, 231 (C11H9N3OS)+, 198 
(C11H8N3O)+,  172 (C10H8N2O)+, 171 
(C7H6Br+2)+,169 (C7H6Br)+, 170 (C10H8N3)+, 158 
(C10H8NO)+, 156 (C10H8N2)˙+,  130 (C9H8N)+, 90 
(C7H6)+, 145 (C5H4Br+2)+,143 (C5H4Br)+,    64 
(C5H4)+.     
 
3-({5-[(4-Bromobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6r): Light 
brown amorphous solid; Yield: 86 %; M.P. 130 
°C; Molecular formula: C18H14N3OSBr; Molecular 
weight: 400 gmol-1; IR (KBr): vmax: 3215 (N-H), 
2927 (C-H Ar),  1484 (C=N), 1478 (C=C Ar), 
848(C-N) and 812 (C-S); 1H-NMR (300 MHz, 
DMSO-d6): δ 11.0 (s, 1H, N-H-1ʹ), 7.45 (br.d, J = 
7.8, 1H, H-4'), 7.38-7.36 (m, 3H, H-2ʹʹ, H-6ʹʹ & H-
7'), 7.33 (br.s, 1H, H-2'), 7.17 (br.d, J = 8.4 Hz, 
2H, H-3'' & H-5''), 7.09 (t, J = 6.9 Hz, 1H, H-5'), 
6.98 (t, J = 7.2 Hz, 1H, H-6'), 4.35 (s, 2H, CH2-
7''), 4.31 (s, 2H, CH2-10'); EIMS: m/z 403 
(C18H14N3OSBr)˙+ [M+4]+, 401 (C18H14N3OSBr)˙+  
[M+2]+, 399 (C18H14N3OSBr)˙+ [M]+, 233 
(C11H9N3OS+2)+, 231 (C11H9N3OS)+, 198 
(C11H8N3O)+, 172 (C10H8N2O)+, 171 
(C7H6Br+2)+,169 (C7H6Br)+, 170 (C10H8N3)+, 158 
(C10H8NO)+, 156 (C10H8N2)˙+,  130 (C9H8N)+, 90 
(C7H6)+, 145 (C5H4Br+2)+,143 (C5H4Br)+,   64 
(C5H4)+.     
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3-({5-[(4-Fluorobenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6s): Brown 
amorphous solid; Yield: 90 %; M.P. 84 °C; 
Molecular formula: C18H14N3OSF; Molecular 
weight: 339 gmol-1; IR (KBr): vmax: 3245 (N-H), 
2932 (C-H Ar), 1485 (C=N), 1480 (C=C Ar), 850 
(C-N) and 825 (C-S); 1H-NMR (400 MHz, DMSO-
d6): δ 11.0 (s, 1H, N-H-1ʹ), 7.51 (br.d, J = 7.4 Hz, 
1H, H-4'), 7.38 (br.s, 1H, H-7'), 7.37 (dist. dd, 
J(a,b&a, 19F) = 8.8, 5.6 Hz, 2Hb, H-2'' & H-6''),7.35 
(br.d, J = 8.0 Hz, 1H, H-2'), 7.09 (t, J = 6.9 Hz, 
1H, H-5'), 7.00 (t, J(b,a&b, 19F) = 8.8 Hz, 2Ha, H-3'' & 
H-5''), 6.98 (t, J = 7.2 Hz, 1H, H-6'), 4.55 (s, 2H, 
CH2-7''), 4.31 (s, 2H, CH2-10'); EIMS: m/z 341 
(C18H14N3OSF )˙+ [M+2]+, 339 (C18H14N3OSF )˙+ 
[M]+, 233 (C11H9N3OS+2)+, 231 (C11H9N3OS)+, 
198 (C11H8N3O)+,   172 (C10H8N2O)+, 170 
(C10H8N3)+,  158 (C10H8NO)+, 156 (C10H8N2)˙+,  
130 (C9H8N)+, 109 (C7H6F)+, 90 (C7H6)+, 83 
(C5H4F)+.  64 (C5H4)+.     
 
3-({5-[(2-Methylbenzyl)sulfanyl]-1,3,4-
oxadiazol-2-yl}methyl)-1H-indole (6t): Light 
brown amorphous solid; Yield: 73 %; M.P. 126 
°C; Molecular formula: C19H17N3OS; Molecular 
weight: 335 gmol-1; IR (KBr): vmax: 3245 (N-H), 
2930 (C-H Ar), 1480 (C=N), 1470 (C=C Ar), 840 
(C-N) and 810 (C-S); 1H-NMR (400 MHz, 
DMSO-d6): δ 11.0 (s, 1H, NH-1ʹ), 7.48 ( d, J = 8.0 
Hz, 1H, H-4'), 7.36 (d, J = 8.0 Hz, 1H, H-7'), 7.31 
( br.s, 1H, H-2'), 7.14-7.12 (m, 3H, H-3'', H-4'' & 
H-5''), 7.09 (t, J = 8.0 Hz, 1H, H-5'), 7.00 (t, J = 
7.8 Hz, 1H, H-6'),6.97 ( d, J=4.8Hz, 1H, H-6''), 
4.41 (s, 2H, CH2-10'), 4.32 (s, 2H, CH2-7''), 2.29 
(s, 3H, CH3-2''); EIMS: m/z 337 (C19H17N3OS)˙+ 
[M+2]+, 335 (C19H17N3OS)˙+ [M]+, 233 
(C11H9N3OS+2)+,  231 (C11H9N3OS)+, 198 
(C11H8N3O)+,   172 (C10H8N2O)+, 170 (C10H8N3)+,  
158 (C10H8NO)+, 156 (C10H8N2)˙+,  130 
(C9H8N)+,105 (C8H9)+, 90 (C7H)+, 79 (C6H7)+,  64 
(C5H4)+.   
 
3-({5-[(3-Nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-
2-yl}methyl)-1H-indole (6u): Dark brown 
amorphous solid; Yield: 78 %; M.P. 101 °C; 
Molecular formula: C18H14N3OS; Molecular 
weight: 366 gmol-1; IR (KBr): vmax: 3240 (N-H), 
2931 (C-H Ar), 1480 (C=N), 1475 (C=C Ar), 845 
(C-N) and 820 (C-S); 1H-NMR (300 MHz, DMSO-
d6): δ11.0 (s, 1H, N-H-1ʹ), 8.30 (br.s, 1H, H-2''), 
8.08 (d, J = 8.1 Hz, 1H, H-4''), 7.72 (br.d, J = 7.5 
Hz, 1H, H-6''), 7.49 (br.d, J = 7.8 Hz, 1H, H-4'), 
7.44 (br.t, J = 7.8 Hz, 1H, H-5''), 7.35 (br.d, J = 
8.1 Hz, 1H, H-7'), 7.30 (br.s, 1H, H-2'), 7.07 (t, J 
= 6.9 Hz, 1H, H-5'), 6.96 (t, J = 7.2 Hz, 1H, H-6'), 
4.55 (s, 2H, CH2-7''), 4.29 (s, 2H, CH2-10'); 
EIMS: m/z 368 (C18H14N4O3S)˙+ [M+2]+, 366 
(C18H14N4O3S)˙+ [M]+, 233 (C11H9N3OS+2)+, 231 
(C11H9N3OS)+, 198 (C11H8N3O)+,  172 
(C10H8N2O)+, 170 (C10H8N3)+,  158 (C10H8NO)+, 
156 (C10H8N2)˙+,  136 (C7H6NO2)+ ,130 (C9H8N)+, 
110 (C6H4NO2)+, 64 (C5H4)+. 
 
DISCUSSION 
 
In Figures 1 and 2, the 1H-NMR spectra of the 
compounds 3-{[5-(Allylsulfanyl)-1,3,4-oxadiazol-
2-yl]methyl}-1H-indole (6i) and 3-[(5-
(Ethoxycarbonylmethylsulfanyl)-1,3,4-oxadiazole-
2-yl)methyl]-1H-indole (6j) are provided. The 
compound 6u was obtained as a dark brown 
amorphous solid; yield: 78 % and m. p. 101 °C 
and the molecular formula C18H14N3OS was 
ascertained by counting the number of protons in 
the 1H-NMR spectrum and EIMS molecular ion 
peak at m/z 366. Infrared spectrum 
demonstrated N-H stretching at 3240 cm-1 and 
aromatic C-H stretching at 2931 cm-1. C=N 
stretching was observed at 1480 cm-1 and 
aromatic C=C stretching at1475 cm-1. C-N gave 
stretching at 845 cm-1 and C-S at stretching at 
820 cm-1. In  the aromatic region of 1H-NMR 
spectrum, a broad singlet at δ 8.30 (s,1H, H-2''), 
two doublets and one triplet  at δ 8.08 (d, J = 8.1 
Hz, 1H, H-4''), 7.72 (d, J = 7.5 Hz, 1H, H-6'') and 
7.44 (t, J = 7.8 Hz, 1H, H-5'') acquiring 
deshielded position due to the vicinity of an 
electron withdrawing nitro group which confirmed 
the substitution of 3-nitrobenzyl group on the 
parent indole-bearing oxadiazole molecule (4). 
Another set of two doublets appeared at δ 7.49 
(J = 7.8 Hz, 1H, H-4') and 7.35 (J = 8.1 Hz, 1H, 
H-7') having an integration of one proton each for 
H-4' & H-7' of the indole moiety. A broad singlet 
of one proton appeared at δ 7.30 (1H, H-2') of 
indole moiety. Two triplets resonated at δ 7.07 (J 
= 6.9 Hz, 1H, H-5') and δ 6.96 (J = 7.2 Hz, 1H, 
H-6') belonging to phenyl ring of indole moiety. In 
the aliphatic region, a sharp singlet appeared at 
δ 4.55, a contributor of two methylene protons at 
C-7'', which confirms the attachment of 3-
Nitrobenzyl group at the thiol position of 1,3,4-
oxadizole ring. Another singlet appeared slightly 
up-field with integration of two protons of C-10' at 
δ 4.29 (2H, CH2-10').  EIMS data further 
supported this structure by revealing base peak 
at m/z 130 for (C9H8N)+ and other major 
fragments at m/z 231(C11H9N3OS)+ ,156 
(C10H8N2)˙+, 172 (C10H8NO)+, 170 (C10H8N3)+,  
158 (C10H8NO)+  for indole moiety. Fragments of 
3-Nitrobenzyl substituent were observed at m/z 
136 (C7H6NO2)+, 110 (C6H4NO2)+, 64 (C5H4)+. On 
the basis of these features, the structure of 
compound 6u was given as 3-({5-[(3-
nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}methyl)-
1H-indole. Similarly, the structures of other S-
alkylated/aralkylated 2-(1H-indole-3-ylmethyl)-
1,3,4-oxadiazole-5-thiols were also characterized 
by spectroscopic techniques. 
Rubab et al 
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CONCLUSION 
 
All the synthesized compounds (6a-6u) were 
obtained in good yields and their structures were 
elucidated by IR, 1H-NMR, and EI-MS spectral 
analysis. It is hoped that further studies on 
possible biological activities of these compounds 
might produce useful results for the 
pharmaceutical industries. 
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